within Pharmacolibrary.Drugs.ATC.C;

model C07FB13
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.001,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.2,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600,            
    Vdp             = 0.3,
    k12             = 50,
    k21             = 50
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C07FB13</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Combination of metoprolol, a beta-1 adrenergic blocker, and amlodipine, a dihydropyridine calcium channel blocker. Used to treat hypertension and angina pectoris. Both drugs are approved and widely used for cardiovascular diseases.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult subjects based on individual drug profiles, as no published studies for the combination product are available.</p><h4>References</h4><ol><li><p>Pham, P, et al., &amp; Brown, JD (2020). Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function. <i>JAMA network open</i> 3(4) e203593–None. DOI:<a href=&quot;https://doi.org/10.1001/jamanetworkopen.2020.3593&quot;>10.1001/jamanetworkopen.2020.3593</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32329770/&quot;>https://pubmed.ncbi.nlm.nih.gov/32329770</a></p></li><li><p>Sarkar, AK, et al., &amp; Pal, TK (2008). Simultaneous determination of metoprolol succinate and amlodipine besylate in human plasma by liquid chromatography-tandem mass spectrometry method and its application in bioequivalence study. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 873(1) 77–85. DOI:<a href=&quot;https://doi.org/10.1016/j.jchromb.2008.07.040&quot;>10.1016/j.jchromb.2008.07.040</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18760977/&quot;>https://pubmed.ncbi.nlm.nih.gov/18760977</a></p></li><li><p>Bialy, LP, et al., &amp; Mlynarczuk-Bialy, I (2018). Mucosal delivery systems of antihypertensive drugs: A practical approach in general practice. <i>Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia</i> 162(2) 71–78. DOI:<a href=&quot;https://doi.org/10.5507/bp.2018.022&quot;>10.5507/bp.2018.022</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29765168/&quot;>https://pubmed.ncbi.nlm.nih.gov/29765168</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C07FB13;
